Skip to Content
Merck
All Photos(2)

Key Documents

View All Documentation

719846

Sigma-Aldrich

Resomer® X 206 S, poly(dioxanone)

Synonym(s):

PDS

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

Linear Formula:
(C4H6O3)n
CAS Number:
29223-92-5
MDL number:
MFCD00868119
UNSPSC Code:
12162002
NACRES:
NA.23

form

solid

Quality Level

200

degradation timeframe

<6 months

inherent viscosity

1.5-2.2 dL/g, 0.1 % (w/v) in hexafluoroisopropanol(30 °C, Ubbelohde) (size 0c glass capillary viscometer)

transition temp

Tg −10-−5 °C
Tm 110-115 °C

storage temp.

−20°C

SMILES string

O1CCOC(=O)C1

InChI

1S/C4H6O3/c5-4-3-6-1-2-7-4/h1-3H2

InChI key

VPVXHAANQNHFSF-UHFFFAOYSA-N

Related Categories

General description

Polydioxanone (PDO) is a colorless, crystalline, highly flexible and resorbable biopolymer.

Application

PDO is widely used as a monofilament wound suture. PDO/elastin-based blends prepared by electrospinning may be used as cardiovascular grafts.

Legal Information

Product of Evonik
RESOMER is a registered trademark of Evonik Rohm GmbH

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
STBL2265
STBK7114
STBJ5547
STBH2283
STBG4755V

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Jean W M Gardeniers et al.
Clinical orthopaedics and related research, 471(7), 2225-2230 (2013-03-06)
Surgical treatment options for sternoclavicular joint luxations described in the literature are numerous, although all have limitations. Therefore, there is no favorable surgical treatment for sternoclavicular luxations when nonoperative treatment has failed. We developed the polydioxanone (PDS) envelope plasty, a
Mitchell D Eggers et al.
Journal of vascular and interventional radiology : JVIR, 23(8), 1023-1030 (2012-07-31)
To test absorbable materials as a prelude to development of an absorbable vena cava filter for the prevention of pulmonary embolism (PE). Three absorbing polymer candidates, poliglecaprone (Monocryl; sizes 4-0 and 1), polyglactin (Vicryl; sizes 4-0 and 1), and polydioxanone
O Hakimi et al.
European cells & materials, 24, 344-357 (2012-10-24)
Rotator cuff tendon pathology is thought to account for 30-70 % of all shoulder pain. For cases that have failed conservative treatment, surgical re-attachment of the tendon to the bone with a non-absorbable suture is a common option. However, the failure
Falk Birkenfeld et al.
The Journal of craniofacial surgery, 23(4), 953-956 (2012-07-11)
The objectives of this study were (i) to evaluate different fracture mechanisms for orbital floor fractures and (ii) to measure forces and displacement of intraorbital tissue after orbital traumata to predict the necessity of strength for reconstruction materials. Six fresh
Tissue hyperplasia following placement of a biodegradable stent for a refractory esophageal stricture: treatment with argon plasma coagulation.
F L Dumoulin et al.
Endoscopy, 44 Suppl 2 UCTN, E356-E357 (2012-10-04)
View All Related Papers

Articles

Segmented Copolymers of p-dioxanone, Glycolide, and Lactide: Advantages and Applications in Biomedical

Main features of p-dioxanone, glycolide and lactide based copolymers

RESOMER® - Biodegradable Polymers for Sutures, Medical Devices, Drug Delivery Systems and Tissue Engineering

Interest in utilizing biodegradable polymers for biomedical applications has grown since the 1960s.

Biodegradable Polyester Nanoparticle Formation

AliAliphatic polyesters, including polylactide and polyglycolide, are biodegradable polymers widely used in medical applications.

Therapeutic Nanoparticles Harness Myeloid Cells for Brain Tumor-Targeted Delivery and Immunomodulation

Immunosuppressive tumor-associated myeloid cells (TAMC) are responsible for glioblastoma (GBM) resistance to immunotherapies and existing standard of care treatments. This mini-review highlights recent progress in implementing nanotechnology in advancing TAMC-targeted therapies for GBM.

See All

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service